Get more details from our experts on the evaluation phase, nebulizer customization and commercialization
Evaluation
Jonas Knoch, Business Development Manager eFlow, provides valuable insights into the early evaluation of drug formulation and nebulizer to support effective inhalation therapy.
Customization
Dr. Benjamin Heine, Technology Platform Leader eFlow, gives you an idea of the methods used to customize eFlow® Technology nebulizers for your drug formulation.
Development
Dr. Markus Tservistas, Senior Project Leader eFlow, explains how the previous evaluation work is continued in the development stage and how we can support clinical trials and regulatory submissions.
Commercialization
Matthias Brosig, Director eFlow Alliance Operations, shares insights how we transmit drug-nebulizer combination products efficiently from development to commercial stage while supporting your market access activities.
Insights from our experts regarding device usability and digital solutions for increasing therapy adherence
Usability
Martin Schlun, Director eFlow Development & Technology, shares insights on how we optimize the nebulizer usability and thus adherence.
Digital Solutions
Dr. Carola Fuchs, Director e-Health Solutions, talks about how we can add value to patients and ultimately to you as a partner with our digital solutions.
